ArticleLupus science & medicine2022

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.

Tsuneyasu Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.